A comparison of the therapeutic efficacy of Tenofovir Disoproxil Fumarate and Entecavir in patients with chronic Hepatitis-B
Compared with ETV, TDF has comparable adverse reaction profile but has more significant clinical effects in patients with CHB, improving HBeAg seroconversion rate, ALT normalization rate, and HBV DNA negative conversion rate. TDF is associated with lower HBV DNA levels after treatment and better improvements in liver function of patients.
Authors
- Liping Wu (ORCID: https://orcid.org/0000-0002-7423-2790)
- Huan Wang (ORCID: https://orcid.org/0000-0002-4870-466X)
Institutions
- Integrated Chinese Medicine (China) (HK)
- Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN)
Publication Details
- Journal
- Pakistan Journal of Medical Sciences
- Published
- 2024-10-19
- DOI
- https://doi.org/10.12669/pjms.40.10.10307
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00